Reports Q2 revenue $496.3M, consensus $493.56M. Joe Kiani, Chairman and Chief Executive Officer of Masimo, said, “Our team’s record-breaking contracting efforts, exceptional execution of margin expansion initiatives and continued innovation drove strong results for shareholders in the second quarter. On the back of that performance and our growing momentum in the healthcare market, we are increasing our full-year 2024 guidance for healthcare revenue, consolidated operating income and consolidated EPS.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASI:
- MASI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Masimo: SafetyNet RPM reduces readmission and ED visits post surgery
- Masimo holder Politan comments on company’s ‘latest entrenchment maneuvers’
- Masimo files commences litigation against Politan Capital Management
- Masimo responds to Politan’s continuing misrepresentations